caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1861585077

Saradha PerinbasekarM.D.

NephrologyCarmel, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Saradha Perinbasekar's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 26 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Jaimin Shah
Interventional Radiology · Morristown, NJ
62222
Michael Capicotto
Nephrology · Brewster, NY
56217
Bramdeo Singh
Hospitalist · Poughkeepsie, NY
52181
LIBERTY RC INC38557
Tsohuang Wu
Internal Medicine · Carmel, NY
36143
SCHWARTZ, IRA34170
NPI 125533553531332
Raymond Yun
Emergency Medicine · Tacoma, WA
3076
Philip Amatulle
Diagnostic Radiology · Fort Myers, FL
3070
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
2976
Maddipoti Choudry
Cardiology · Brewster, NY
2972
Glenn Boyar
Cardiology · Carmel, NY
2888
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
494
Unique beneficiaries
—
Total services
1,121
Distinct HCPCS
8
Medicare payment
$129K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 690 Nephrology providers in NY — above median (cohort median 875).
PRESCRIBING · PART D · 2024
Total Rx claims
363
Beneficiaries
—
Total drug cost
$92K
Distinct drugs
18
Brand share
17.4%
Top prescribed drugs
Amlodipine Besylate53 claims
Furosemide51 claims
Dapagliflozin Propanediol30 claims
Allopurinol25 claims
Carvedilol19 claims
QUALITY · MIPS · 2024
Final MIPS score
49.5
Quality
46.7
Cost
82.2
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-3.06%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$1K
Payment records
61
By payment type
Food and Beverage$1K
Education$59